| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000043672 |
| Receipt No. | R000049871 |
| Scientific Title | A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract. -Single group before-after test- |
| Date of disclosure of the study information | 2021/09/01 |
| Last modified on | 2021/09/17 (Ver. 2) |
| Basic information | ||
| Public title | Study on the arrival of live bifidobacteria in the gastrointestinal tract. -Single group before-after test- | |
| Acronym | Study on the arrival of live bifidobacteria in the gastrointestinal tract. | |
| Scientific Title | A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract. -Single group before-after test- | |
| Scientific Title:Acronym | A study on the viability of bifidobacteria ingested as an acid-resistant processed preparation in the digestive tract. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Verification of survival of bifidobacteria in human feces before and after ingestion of acid-resistant bifidobacteria supplement |
| Basic objectives2 | Others |
| Basic objectives -Others | Verification of supplement on acid resistance processing technology |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection of certain live Bifidobacterium in feces.
Time: Before and after the intervention (0day, 14days) |
| Key secondary outcomes | Viable cell count of certain Bifidobacterium in feces |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Bifidobacterium-containing acid-resistant preparation
Intervention period:14days |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Healthy men and women 20 to 64 years old
2.Subjects who have defecation every day and can collect stool at the designated date and time 3.Subjects who have received sufficient explanation about the purpose and content of the exam, have the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the exam in writing. |
|||
| Key exclusion criteria | 1. Subjects who tend to have loose stools or constipation
2. Subjects who cannot stop the intake of foods containing certain Bifidobacterium from the screening test to the end of the 2-week test. 3. Subjects who are taking drugs that affect digestion and absorption, such as antibiotics 4. Subjects who cannot stop the intake of medicines, quasi-drugs, and health foods that affect the test during the test period. 5. Subjects with food allergies 6. Subjects who consume a large amount of alcohol on a daily basis 7. Subjects who have urgent medical treatment or have serious complications 8. Subjects with digestive disorders or surgical history that affect digestion and absorption and defecation 9. Subjects with a history of irritable bowel syndrome or a current medical history 10. Subjects background Persons who are judged to be inappropriate as subjects based on the answers to the questionnaire 11. Pregnant, willing to become pregnant during the exam, breastfeeding 12. Subjects with a history of drug dependence, alcohol dependence, or current medical history 13. Subjects who have participated in or are willing to participate in tests that take other foods or use drugs, and tests that apply cosmetics and drugs 14. Subjects judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | FANCL Corporation | ||||||
| Division name | Research Institute, Health science research center | ||||||
| Zip code | 244-0806 | ||||||
| Address | 12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa | ||||||
| TEL | 045-820-3443 | ||||||
| ke-yui@fancl.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | KSO Corporation | ||||||
| Division name | Sales department | ||||||
| Zip code | 105-0023 | ||||||
| Address | 1-9-7, Shibaura, Minato-ku, Tokyo The 7th floor of Shibaura omodaka building | ||||||
| TEL | 03-3452-7733 | ||||||
| Homepage URL | |||||||
| yoshikawa@kso.co.jp | |||||||
| Sponsor | |
| Institute | KSO Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FANCL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethical Committee of Kobuna Orthopedics Clinic |
| Address | 5-656-17Joutou-machi,Maebashi-shi,Gunma |
| Tel | 027-212-5608 |
| sagawa@mc-connect.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 品川シーズンテラス健診クリニック/Shinagawa Season Terrace Health Care Clinic |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049871 |